The relative contributions of type 1 and 2 T-helper (Thl and Th2) cell-derived interleukin (IL-5), granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-3 were studied in the regulation of sequential events in the development of eosinophilia. Using eosinophils from normal donors and neutralizing antibodies that selectively block cytokine activities, we analyzed the effects of these cytokines in supernatants (SN) of well-characterized allergen-specific Th2 and T h l T-lymphocyte clones (TLC) generated from atopic and nonatopic individuals, respectively. Eosinophil colony formation from CD34+ bone marrow progenitor cells in semisolid cultures could be induced both by T h l and Th2 SN, mainly mediated by the synergistic effects of GM-CSF and IL-3. whereas IL-5 had only a minor additive effect. High production of mature eosinophils in liquid cultures of unseparated mononuclear bone marrow cells could only be induced by Th2 SN, which could be more than 90% blocked by anti-IL-5, but not by anti- OSINOPHILIA is a common feature of atopic dis-E characterized by selectively enhanced production of eosinophils in the bone marrow, elevated numbers of eosinophils in the peripheral blood, and accumulation of eosinophils in affected tissues. The presence of high numbers of activated eosinophils in lung and/or skin tissue during late-phase allergen-induced inflammatory reactions causes serious tissue damage, due to the release of cytotoxic granule-derived mediators and reactive oxygen species5a6
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Many of the sequential events in the development of eosinophilia are controlled by soluble cytokines. Extensive studies with recombinant cytokines have shown that eosinophil differentiation and proliferation in the bone marrow, the extension of their life span in the periphery, the attraction of eosinophils to the sites of inflammation, and the activation of their destructive function are primarily due to the activities of interleukin (IL-5), granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-3.'-I5 These cytokines can be secreted by T ~e l l s , '~,~~ mast ~e l l s , ' *~~~ and even by the eosinophil itself.2G22 However, the T cell is considered to be the main regulatory cell type in this respect, since development of eosinophilia upon infection with helminthic parasites does not occur in athymicZ3 or T-cell-deficient mice."
IL-5-transgenic mice develop eosinophilia:5 and helminth-induced eosinophilia in normal mice can be prevented by administering a neutralizing anti-IL-5 antibody,26 implicating IL-5 as a crucial cytokine in this process. We have recently demonstrated that allergen-specific Tlymphocyte clones (TLC) from the peripheral blood" and lesional skin2* of atopic individuals are type 2 T-helper (Th2) cells that produce high quantities of IL-5, whereas TLC responsive to the same allergen obtained from nonatopic control donors are type 1 T-helper (Thl) cells that produce no or only minimal amounts of IL-5.I7 The correlation in atopic patients between high T-cell activity and elevated serum IL-5 levels'5 and the demonstration in atopic patients of mRNA expression of the Th2-associated gene cluster in biopsies from experimentally allergen-challenged skin,29 as or anti-GM-CSF. Chemotaxis of mature peripheral blood eosinophils could equally well be induced by T h l and Th2 SN, although the relative contribution of the individual cytokines was clearly different in the two sets of SN. Priming of platelet-activating factor (PAF) release by peripheral blood eosinophils was regulated by additive effects of the three cytokines and was stronger induced by the Th2 SN than by the T h l SN. The present results indicate that IL-5, GM-CSF, and IL-3 control eosinophils throughout the course of development of eosinophilia, having different individual contributions in different compartments. The apparent strong and selective IL-5-dependence of certain yet undefined steps in eosinophil production in the bone marrow supports the concept of the generally assumed causal relation between predominant activation of IL-5-producing Th2 cells in response to allergens and development of eosinophilia in atopic disease. 0 1993 by The American Society of Hematology.
well as in freshly isolated T cells from bronchoalveolar lavage suggest that Th2 cells are indeed activated in vivo. Together, these findings suggest that development of eosinophilia is caused by overproduction of IL-5 due to predominant Th2 activation in response to allergens. This hypothesis is supported by the fact that eosinophilia does not occur in diseases, such as tuberculoid leprosy,31 that are mediated by non-11-5-producing Th 1 cells.32
However, as in the mouse,33 human Thl and Th2 clones readily produce GM-CSFI7 and IL-3 (our present results), cytokines with strong eosinophil-promoting properties in different compartments. If indeed eosinophilia is due to overproduction of IL-5, this would implicate that one or more steps in the development of eosinophilia are strictly IL-5-dependent and cannot be mediated by IL-3 and/or GM-CSF alone.
In the present comparative study, we investigated the relative contributions of IL-5, GM-CSF, and IL-3 in the supernatents (SN) of well-characterized allergen-specific high-IL-5-producing Th2 clones and low-11-5-producing Th 1 1472 WIERENGA ET AL ~l o n e s '~~~~ to the regulation of sequential processes associated with the development of eosinophilia. These relative contributions are the net result of the effects of the individual cytokines, cross-modulation between the different cytokines, and the ratio in which they are secreted by T cells from different functional subsets. As a source of eosinophils, we used bone marrow and peripheral blood of nonatopic individuals, because a large proportion of the eosinophils in atopics are already in an activated ~t a t e ,~~.~~ which results in enhanced reactivity to certain stim~li'~,~' and makes them less appropriate for the investigation ofdevelopment of eosinophilia.
MATERIALS AND METHODS
Antibodies. Murine monoclonal antibodies (MoAbs) used for T-cell activation or cell-labeling were CLB-T3/3 (antihuman CD3; IgGZa), CLB-FcR-gran/ 1 (antihuman CD16; IgG2a), and CLB-28/ 1 (antihuman CD28; IgGI) obtained from The Central Laboratory Blood Transfusion Service (Amsterdam, The Netherlands); OKT3 (antihuman CD3; IgG2a) obtained from Ortho Pharmaceutical (Raritan, NJ); and CD14 (antihuman CD14; IgG2b) and BI3C5 (antihuman CD34; IgGI) obtained from Sera-Lab (Crawley Down, UK). VIM-D5 (antihuman CD15; IgM) was a gift of Dr W. Knapp (Institute for Immunology, Vienna, Au~tria).~'
Cytokines and cytokine-neutralizing antibodies. Human recombinant (r)IL5 was a gift of Dr D. Fattah (Glaxo Group Research, Greenford, UK, specific activity, 0.3 X lo6 U/mg). Human rIL3 (specific activity, 10' U/mg) and human rGM-CSF (specific activity, 2.5 X IO' U/ml) were purchased from Genzyme (Boston, MA). Rat antimouse IL-5 MoAb TRFK 5 (IgGI), which cross-reacts and neutralizes human IL-5>9 was kindly provided by Dr H.F.J. Savelkoul (Department of Immunology, Erasmus University, Rotterdam, The Netherlands) and neutralizes more than 98% of the IL-5 activity in both Th2 SN used in this study at a concentration of 10 pg/mL, as assessed in the B I3 bioassay. The polyclonal sheep antihuman GM-CSF antiserum (a gift of Dr S.C. Clark, Genetics Institute, Cambridge, MA),@ used in the bone marrow experiments, completely blocks the activity of 100 ng/mL rGM-CSF in the colony-formation assay at a dilution of 1/5OO. This antiserum had significant background effects in the platelet-activating factor (PAF)-release assays and was therefore not used in the experiments with peripheral blood eosinophils. Neutralizing mouse MoAb to human IL-3 (F13-267; IgG1) 41 and human GM-CSF (IgGI) were gifts of Dr G. Zenke (Preclinical Research, Sandoz, Basel, Switzerland). The neutralizing capacities of these MoAbs were tested in a serum-treated Zymosan (STZ)-induced PAF release assay primed with recombinant cytokines. Anti-IL3 MoAb neutralized more than 90% of the activity of 2 ng/mL rIL3 at a concentration of 10 pg/mL. Anti-GM-CSF MoAb was less potent, blocking approximately 60% of the activity of 0.2 ng/mL rGM-CSF at a dilution of 1:50. Based on these pilot experiments (data not shown), the antibodies were used at the above-mentioned concentrations in all experiments. All anticytokine antibodies used are highly specific and show no cross-reactivity with any other cytokine.
Housedust mite Dematophagoides pteronyssinus-specific CD4+ TLC were obtained from previously characterized generated from the peripheral blood of atopic patients with atopic dermatitis (Th2 clone MBB.AA60) or allergic asthma (Th2 clone EBA.AI4), and from a nonatopic control individual (Thl clones MBE.AA40 and MBE.AA42).
Preparation (immobilized by coating the culture wells with a 1/1O,OOO dilution of ascites) and soluble affinity-purified antLCD28 MoAb CLB-28/ 1 (1 pg/mL). Stimulation was performed in Iscove's modified Dulbecco's medium (GIBCO, Paisley, UK) supplemented with 10% complement (C)-inactivated fetal calf serum (FCS; Flow, Irvine, UK), human transferrin (35 mg/L; Behring, Marburg, Germany), human insulin ( 150 IU/L; Novo, Bagsvaerd, Denmark), 2-mercaptoethanol (2-ME) (3.5 pL/L; Merck, Munich, Germany), and gentamycin (80 mg/L; Duchefa, Haarlem, The Netherlands) at 37°C in a humidified atmosphere containing 5% CO,. Cell-free SN were collected after 24 hours and stored in aliquots at -20°C. Separate but similar cultures were tested in a T-cell proliferation assay, as Cytokine assays in TLC SN. Secretion of GM-CSF and IL-3 was measured using commercial enzyme-linked immunosorbent assay (ELISA) kits from Medgenix Diagnostics (Soesterberg, The Netherlands). Bioassays for IL-2 (CTLL-2 assay) and IL-5 (B13 assay) and solid-phase ELISA systems for measuring IL-4 and gamma interferon (IFN-7) were all described in detail elsewhere!"' Preparation of bone marrow mononuclear cell suspensions. Bone marrow was obtained from hematologically normal adults, following informed consent, by posterior iliac crest puncture (Dr Daniel den Hoed Cancer Center, Rotterdam, The Netherlands) or by sternum puncture (Academisch Medisch Centrum, Amsterdam, The Netherlands), using protocols approved by the ethics committees of both hospitals. The marrow was collected in heparinized Hank's balanced salt solution (HBSS) and mononuclear cells were prepared by flotation (30 minutes, 1 , OOOg) on Lymphoprep (1.077 g/mL; Nycomed, Torshov, Norway) and used as starting material for the isolation of progenitor cells and to study eosinophil production in liquid bone marrow cultures. The percentage ofeosinophilic cells in these fractions usually was 0.1% to 0.3%, as determined by analysis of cytospin preparations stained according to May-Griinwald Giemsa.
Isolation of bone marrow progenitor cells. Mononuclear bone marrow cells were enriched for progenitor cells as described previously. 46 Briefly, accessory cells were depleted by C-mediated cytolysis using pooled 3-to 4-week-old rabbit C (40%; Pel Freez Biologicals, Rogers, AR) and a cocktail of MoAbs against cell-type-specific surface antigen (Ag) expressed on mature monocytes (antLCD14 MoAb CD14; final dilution, 1/50), myeloid cells (anti-CDI 5 MoAb VIM-D5; final dilution, l/lOO), or T cells (anti-CD3 MoAb OKT3; final dilution, 1/10), but not on progenitor cells. Recovered cells were washed and labeled with mouse anti-CD34 (BI3C5; final dilution, 1/100), a membrane Ag expressed on hematopoietic progenitor cells?7 Mouse label was visualized with goat antimouse fluorescein isothiocyanate (FITC, 1/40; Nordic, Tilburg, The Netherlands) followed by positive selection of CD34+ cells on a FACS 440 (Becton Dickinson, Mountain View, CA). The final cell fraction, 2% to 5% of the initial number of mononuclear cells, normally consisted of more than 95% CD34+ cells with a viability of more than 98%.
Peripheral blood eosinophils were isolated from normal healthy donors, essentially as described previously?' In short, buRy coats were prepared from the peripheral blood of healthy volunteers. Mononuclear cells were removed by flotation (20 minutes, 1,OOOg) on Ficoll(l.077 g/mL). Erythrocytes in the pellet were lysed in an isotonic NH4CI solution and recovered granulocytes were washed and labeled (30 minutes, 0°C) with anti-CDI6 MoAb CLB-FcR-gran/l (1.2 &lo7 cells/ mL) in HBSS plus 1% human serum albumin (Central Laboratory Blood Transfusion Service). CD I6 (Fc,R-111) is expressed on neutrophils, but not on normal resting eosinophil^.^^ Subsequently, to confirm stimulation of the TLC.
Purifrcation of peripheral blood eosinophils.
For personal use only. on October 25, 2017. by guest www.bloodjournal.org From Colony formation assays. Freshly enriched CD34+ bone marrow progenitor cells were cultured, as de~cribed,'~ in 35-mm Petri dishes (k4 X 103/dish) containing 2.5 mL of a semisolid solution of 1.2% methylcellulose (Dow Chemical, Midland, MI) in Iscove's modified Dulbecco's medium, supplemented with 30% heparinized autologous plasma, 0.075% bovin serum albumin (BSA) Fraction V (Sigma Chemical, St Louis, MO), human transferrin (0.6 mg/mL; Behring), lecithin (20 pg/mL; Merck), sodium selenite (0.18 ng/mL; Merck), 2-ME (3.5 pl/L; Merck), and penicillin and streptomycin as antibiotics (both 100 U/mL; GIBCO), at 37°C in a humidified atmosphere containing 5% CO,. Cultures were stimulated for 15 days with serial dilutions of Th I or Th2 SN, preincubated or not for 1 hour with neutralizing antibodies against IL-5, GM-CSF, or IL-3. Eosinophilic colonies derived from individual cells were scored by inverted light microscopy and calculated as the mean of duplicate cultures only, due to the large volumes of TLC SN required in these experiments.
Liquid bone marrow cultures. Mononuclear bone marrow cells were cultured ( lo5/ 100 pL) for 2 1 days in Costar 96-well round-bottom culture plates in the same medium in which the TLC SN were prepared, at 37°C in a humidified atmosphere containing 5% CO,. Triplicate cultures were stimulated with serial dilutions of Thl or Th2 SN in the absence or presence of neutralizing antibodies against IL-5, GM-CSF, or IL-3. To allow neutralization of cytokine activities before the onset of the cultures, SN were preincubated with the respective antisera 1 hour in advance. According to the method described by Clutterbuck et a],* 50 pL of the culture SN was replaced weekly with fresh medium containing the appropriate dilutions of TLC SN and antibodies. After 21 days, cultures were resuspended, put onto slides in a cytocentnfuge, and stained according to May-Griinwald Giemsa. Cell viability was assessed by trypan-blue exclusion. Production of eosinophilic cells was determined by light microscopy and calculated as the mean percentage of viable cells in triplicate cultures.
Eosinophil chemotaxis assay. TLC SN-induced chemotaxis of peripheral blood eosinophils was analyzed in a modified Boydenchamber assay, described by Wamnga et al.I4 Serial dilutions of Thl or Th2 SN in HEPES buffer (30 pL) were placed in the lower compartments of 48-well microchemotaxis chambers (Neuroprobe, Cabin John, MD), in the absence or presence of neutralizing antibodies against IL-5, GM-CSF, or IL-3. To allow neutralization of cytokine activity before the onset of chemotaxis, SN were preincubated with the respective antisera 1 hour in advance. Two cellulose nitrate filters were placed between the lower and upper compartments, the upper filter having a pore diameter of 8 pm (Sartorius, SM 1 13; Sartorius, Gottingen, Germany) and the lower filter having a pore diameter of 0.45 pm (Millipore type HA; Millipore, Bedford, MA). Purified eosinophils were placed in the upper compartments ( 105/25 pL). After 2.5 hours of incubation at 3 7 T , the 8-pm upper filters were fixed and stained in Weigert solution: 1% (vol/vol) hematoxylin mixed (1:l) with 70 mmol/L acidic FeCl,. Stained filters were dehydrated with ethanol, made transparant with xylene, and fixed upside down. The number of cells that had passed the upper filter was estimated by counting cells in 10 high-power fields using light microscopy and expressed as the mean of triplicate experiments.
Eosinophil priming and activation. Purified peripheral blood eosinophils were primed (5 X 106mL) with serial dilutions ofThl or Th2 SN in HEPES buffer, supplemented with 2.5 mmol/L taurine, 380 U/mL superoxide dismutase, and 5,000 U/mL catalase (all obtained from Sigma Chemical) to protect lipids from oxidative stress. After 30 minutes of priming at 37"C, serum-treated" Zymosan (STZ) particles were added (0.5 mg/mL, Sigmachemical) as an eosinophil stimulus. After another 30 minutes at 37"C, cells were spun down at 0°C and cell-free eosinophil SN were stored at -70°C under N, until they were analyzed. To determine the degree of eosinophil activation, STZinduced release of PAF was measured in the SN using a commercial "' I radioimmunoassay kit (Du Pont, Boston, MA) and expressed as mean PAF release per lo6 eosinophils in triplicate experiments.
RESULTS

Cytokine analysis of Thl-and Th2-derived SN, We
have previously shown that the cytokine secretion profiles of the Thl and Th2 clones used in this study are intrinsic properties of the TLC, irrespective of the mode of stimulation." Therefore, we stimulated the TLC with the combination of immobilized anti-CD3 and soluble anti-CD28, instead of with specific Ag presented by APC, in order to prevent interference with eosinophil-modulating factors that might be produced by the APC or other accessory cells. Proliferation assays confirmed strong reactivity of all TLC to this combination of mitogenic antibodies (Table 1) . Control experiments did not indicate effects of anti-CD28 on eosinophils (data not shown), excluding interference with residual anti-CD28 in the TLC SN. Secreted cytokines were measured in cell-free SN collected after 24 hours, which proved to be an adequate time point in previous studies with these c10nes.l~ The Th 1 SN contained high amounts of IL-2 and IFN-7, but no substantial IL-4 and IL-5, whereas the Th2 SN contained minimal IL-2 and IFN-y, but high amounts ofIL-4 and IL-5. Both Thl and Th2 SN contained comparable quantities of GM-CSF and, finally, all SN contained substantial amounts of IL-3, although it should be noted that in these particular Thl SN the IL-3 concentrations were about twice as high as in the Th2 SN. IL-3 measurements in SN of larger panels of TLC showed no substantial differences in IL-3 production levels by Thl and Th2 cells (data not shown). Although each of the functional analyses described below were performed with more Thl and Th2 TLC (all characterized by Wierenga et a117,27), data are presented for two Th 1 and two Th2 TLC only, because these particular TLC were included in all experiments and the results with all Th 1 and all Th2 TLC were highly consistent.
Eosinophil colony formation from bone marrow progenitors. To study the effects of Th 1 and Th2 SN on the early eosinophil differentiation process, CD34+ bone marrow progenitor cells were incubated with serial dilutions of TLC SN in a semisolid culture system allowing formation and detection of colonies derived from individual cells. Both Th 1 and Th2 SN induced eosinophil colony formation in a dose-dependent fashion (Fig 1) . Using these particular Thl and Th2 SN, the number of eosinophil colonies was always MBB.AA202' with a higher IL-3 concentration (562 pg/mL) produced more (38 and 49) colonies and was inhibited greater by anti-IL-3 MoAb (48%) as compared with the other two Th2 SN (data not shown). Blocking of IL-5 activity had only slight inhibiting effects, suggesting a minor additive role of IL-5 in this process. The combination of all three antibodies completely abrogated colony formation, giving no evidence for the involvement of other T-cell-derived factors with primary effects on early eosinophil differentiation.
Production of eosinophils from unseparated bone marrow mononuclear cells. The role of T-cell-derived IL-5, GM-
CSF, and IL-3 in the overall regulation ofeosinophil production in the bone marrow was investigated in liquid cultures of unseparated bone marrow mononuclear cells. This complex process may include early and later differentiation steps, as well as proliferation and survival. Cell viability, assessed by trypan-blue exclusion after 2 1 days of culture, was high in all experiments (>90%), but was dramatically decreased in cultures with 1/50 or less diluted TLC SN (data not shown), probably because of acidification of the culture Th2 clones CD34+ bone marrow progenitor cells were cultured as described in the legend to Fig 1, in SN (1 /20) (Fig 2) . However, both Th 1 SN had only minimal effects. Blocking experiments performed in cultures with 1/500 diluted TLC SN demonstrated that eosinophil production in all cultures could almost completely be blocked by anti-IL-5 alone (Table 3) , showing only minimal effects of anti-IL-3 and anti-GM-CSF. This finding implicates strong and selective IL-5-dependence of a yet undefined step in eosinophil production and suggests that, although IL-3 and GM-CSF proved to be crucial in the early phase of eosinophil differentiation, their relative contribution to later processes in the course of eosinophil production is only minimal. The combination of MoAbs against all three cytokines reduced eosinophil percentages to the background levels of cultures without TLC SN, suggesting that no other T-cell-derived factors have primary effects in eosinophil production. Finally, the addition of rIL-5 (5 U/mL) to cultures with 1/50 diluted Thl SN compensated for the inability of these SN to induce eosinophil production, normally yielding up to 50% to 60% eosinophils (data not shown). This finding indicates that lack of substantial IL-5 prevents eosinophil production even in the presence of and GM-CSF and argues against the secretion of suppressive factors by Thl cells.
Chemotaxis of peripheral blood eosinophils. The chemotactic effects of Thl and Th2 SN on peripheral blood eosinophils were examined by analyzing eosinophil migration through 8-pm cellulose nitrate filters in Boydenchamber experiments. All SN tested showed dose-dependent chemotactic effects, not discriminating the potentials 
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of Thl and Th2 SN (Fig 3) . The regulation of eosinophil chemotaxis appeared to be a complex process, as indicated by selective blocking experiments with neutralizing MoAb against IL-5, GM-CSF, and/or IL-3 (Table 4) . Anti-IL-5, in particular, had strong inhibiting effects both on Thl(82% to 92%) and Th2 (88% to 97%) SN-induced chemotaxis. Thl SN-induced chemotaxis could also partially be blocked by anti-GM-CSF (49% to 88%) and by anti-IL-3 (3 I % to 75%), implying synergism between the three cytokines. Th2 SNinduced chemotaxis was partially inhibited by anti-IL-3 (33% to 6 I %). However, anti-GM-CSF consistently failed to inhibit Th2 SN-induced chemotaxis to a substantial ex- For Peripheral blood eosinophils were cultured as described in the legend to Fig 3, in SN (1/100) of Thl or Th2 TLC. Neutralizing MoAbs against IL-5, GM-CSF, or IL-3 were added either alone or all three together. Data are expressed as percentage inhibition of eosinophil migration (mean of three experiments; SD < 15%). as compared with parallel experiments without MoAbs.
tent (0% to 15%). The combination of all three MoAbs abolished eosinophil chemotaxis for 95% or more.
Priming of peripheral blood eosinophils. Eosinophils poorly respond to opsonized particles like STZ, unless they are primed in advance.52 Peripheral blood eosinophils were primed by preincubation in serial dilutions of Thl or Th2 SN, after which PAF release was induced by adding STZ. All TLC SN tested primed eosinophils in a dose-dependent fashion (Fig 4) . The effects of the Th2 SN were consistently stronger than those of the Thl SN, reaching plateau levels between dilutions of I / 1,000 and 1/100. These different potentials could not be ascribed to the high IL-5 concentra- (Table  5) . Relatively strong inhibition of priming was achieved only with anti-GM-CSF both in Thl and Th2 SN. Anti-IL-3 had moderate blocking effects. The combination of all three MoAb blocked eosinophil priming almost completely. The present results suggest additive effects of the three cytokines.
DISCUSSION
The present study indicates that once IL-3-and GM-CSF-dependent early differentiation has occurred, the production of eosinophils in the bone marrow strongly and selectively depends on IL-5. As a consequence, Th2-cellderived SN, containing high amounts of IL-5, have much stronger effects on eosinophil production in cultures of bone marrow mononuclear cells than have Th 1 -cell-derived SN, supporting the concept of a causal relation between predominant Th2 cell activation in response to allergens and the occurrence of eosinophilia in atopic patients. Chemotaxis and priming of peripheral blood eosinophils appeared to be controlled by combined synergistic or additive effects of IL-5, GM-CSF, and IL-3, SN-induced effects at all levels studied were blocked by 95% or more by the simultaneous addition of neutralizing MoAbs against all three cytokines. This finding argues against eosinophil-stimulating effects of these antibodies, complexed or not with the respective cytokine molecules, and against the occurrence of other T-cell-derived factors with primary eosinophil regulating potentials. The existence of modulatory factors produced by T cells cannot be excluded. For example, tumor necrosis factor-alpha (TNF-a) has been shown to play a role in eosinophil colony formation,53 c h e m~t a x i s ,~~ and priming."
Early eosinophil differentiation from bone marrow progenitor cells is regulated by the synergistic effects of GM-CSF and IL-3. As discussed below, the observed minor addi- tive effect of IL-5 may reflect proliferation, rather than early differentiation. The effects of the Thl SN in these experiments were always stronger than those ofthe Th2 SN, which is probably explained by the higher quantities of IL-3 in these particular Thl SN. Nevertheless, Thl and Th2 cells may secrete different levels of eosinophil-modulating factors other than TNF-a, which is produced in comparable quantities by the Thl and Th2 c10nes.I~ A possible candidate is TNF-0, which in the mouse is selectively produced by Thl cells.33 Analysis of TNF-/3 production by our human Th 1 and Th2 clones is underway.
Whereas GM-CSF and IL-3 appear to be the main regulating cytokines in the early differentiation of eosinophils, subsequent steps in their ontogeny and/or expansion seem to be selectively dependent on IL-5. Only the IL-5-containing Th2 SN were able to induce strong dose-dependent eosinophil production in cultures of bone marrow mononuclear cells and this process could exclusively and almost completely be blocked with anti-IG5. The observed minor contribution of GM-CSF and IL-3 in these experiments may be due to their early effects on the small population of CD34+ progenitor cells in these preparations. In line with our present findings are data from Clutterbuck et al obtained with recombinant cytokines; suggesting that IL-5 acts only on a small subset of eosinophil progenitors, but has powerful proliferation-inducing capacities on eosinophilic bone marrow mononuclear cells. It may be hypothesized that the role of IL-5 in the ontogeny of eosinophils is only evident from the moment they have passed the first differentiation phase and become committed to be eosinophils, for instance due to upregulation of expression of the IL-5 receptor. Further research will have to prove the validity of this theory.
Chemotaxis of mature peripheral blood eosinophils by T-cell-derived SN is a complex process regulated by multiple cytokine activities, indicated by the individual inhibitory effects of the three neutralizing anticytokine MoAbs on Th 1 SN-induced chemotaxis. IL-5, in particular, appeared to provide a major contribution even in Thl SN-induced chemotaxis, suggesting that only minimal amounts of this cytokine are required to induce eosinophil chemotaxis. Anti-GM-CSF inhibited Th 1 SN-induced eosinophil chemotaxis, but consistently failed to substantially inhibit Th2 SN-induced chemotaxis. Interestingly, GM-CSF-induced chemotaxis of eosinophils from peripheral blood of mild allergic asthmatic patients is downregulated compared with eosinophils from normal control
The reason for these phenomena is not fully clear, but based on recent studies55 it does not seem unlikely that the chemotactic effect of GM-CSF on eosinophils is hampered by exposure of the eosinophils to high concentrations of IL5. Other modulatory factors may be involved as well but, as far as we know, data on CD4+ T-cell-derived factors, other than TNF-a, that modulate eosinophil chemotaxis have not been reported.
Regarding the chemotactic role of T-cell-derived cytokines, it should be noted that within minutes after local allergenic challenges in atopic patients, eosinophils are attracted mainly by mediators, such as histamine, leukotriene B,, and PAF, released by activated mast cells or basophils.56
Factors released by infiltrated eosinophils may further accelerate the influx. During this immediate response the role of cytokines in eosinophil attraction is probably only a secondary one, because their secretion first requires gene transcription and protein synthesis. These observations suggest that, once eosinophils are present in the blood, their migration into the tissues does not exclusively depend on local Th2 cell activation. The major role of Th2 cells in the early influx of eosinophils may be indirect by inducing IL-4-dependent IgE synthesis57 in the draining lymphoid tissues by which mast cells and basophils are sensitized. A more pronounced role of Th2-cell-derived chemotactic cytokines may of course be expected during the late phase response and in chronically inflamed tissues.
Priming of peripheral blood eosinophils by TLC SN seems to be induced mainly by GM-CSF, with relatively small additive effects of IL-5 and IL-3. A positive correlation was observed between the degree of inhibition of priming by the neutralizing antibodies and the concentrations of the respective cytokines in the TLC SN: the effect of anti-IL-3 was stronger in Th 1 SN-induced priming, the effect of anti-IL-5 was stronger in experiments with Th2 SN, and anti-GM-CSF blocked equally strong in all SN. The strong priming effects of the Th2 SN and the predominant activation of Th2 cells in response to allergens in atopic patients may explain the large numbers of preactivated eosinophils in the peripheral blood of these patients. Considering the apparent limited contribution of IG5 in this process, the reason for the stronger priming effects of the Th2 SN as compared with the Thl SN remains unclear.
The present results confirm that T cells have an important regulatory role in the development of eosinophilia and that the T-cell-derived cytokines JL-5, GM-CSF, and IL-3 control several sequential events. The relative contributions of these cytokines vary from step to step, which may be due to different maturation stages in the different compartments. Interesting is the notion that eosinophil production in the bone marrow critically depends on IG5. The high frequency of IL-5-producing allergen-specific Th2 cells in atopic patient^,'^^'^ therefore, indeed suggests a causal relation with the occurrence of eosinophilia. Inasmuch as IL-5, in contrast to GM-CSF and IL-3, selectively acts on eosinophil~>'*,'~ eosinophil production in the bone marrow may be a potential target for research on development of a therapy that prevents or suppresses eosinophilia without interfering with the functions of other cell types. Present experiments address the question which precise processes (proliferation, differentiation, and/or survival) critically depend on IL-5.
